Sapporo Clinical Laboratory (SSE:9776) Beta: -0.0171 (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SSE:9776 Sapporo Clinical Laboratory Inc SSE:9776
66 GF Score
Price 円2,124.00
GF Value 円1,128.61
! 4 Warning Signs
View Full Analysis

What is Sapporo Clinical Laboratory Beta?

Sapporo Clinical Laboratory SSE:9776 66 Beta is -0.0171 as of Jul. 29, 2026. GuruFocus rates SSE:9776 with a GF Score™ of 66/100 and a GF Value™ of 円1,128.61. The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-29), Sapporo Clinical Laboratory's Beta is -0.0171.


Sapporo Clinical Laboratory  (SSE:9776) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Sapporo Clinical Laboratory Beta Related Terms


Sapporo Clinical Laboratory Beta Historical Data

* Premium members only.

The historical data trend for Sapporo Clinical Laboratory's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sapporo Clinical Laboratory Beta Chart

Sapporo Clinical Laboratory Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.19 -0.20 0.01 0.01 -0.00

Sapporo Clinical Laboratory Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 -0.00 -0.01

Sapporo Clinical Laboratory Beta Competitor Comparison

For the Pharmaceutical Retailers subindustry, Sapporo Clinical Laboratory's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sapporo Clinical Laboratory Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sapporo Clinical Laboratory's Beta distribution charts can be found below:

* The bar in red indicates where Sapporo Clinical Laboratory's Beta falls into.


SSE:9776
66GF Score
Sapporo Clinical Laboratory Inc SSE:9776
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sapporo Clinical Laboratory Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.0171 mean?
Sapporo Clinical Laboratory (SSE:9776) has a Beta of -0.0171 as of Jul. 29, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sapporo Clinical Laboratory and its competitors.
Is Sapporo Clinical Laboratory's Beta too high?
Sapporo Clinical Laboratory's current Beta is -0.0171. Overall, Sapporo Clinical Laboratory has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Sapporo Clinical Laboratory's Beta compare to competitors?
Sapporo Clinical Laboratory's Beta of -0.0171 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sapporo Clinical Laboratory and its competitors. Sapporo Clinical Laboratory's current Beta is -0.0171. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sapporo Clinical Laboratory stock overvalued right now?
Sapporo Clinical Laboratory (SSE:9776) has a current Beta of -0.0171. The stock's GF Value™ is 円1,128.61, compared to a current price of 円2,124.00 — trading 88.2% above its estimated fair value. The current Beta is -0.0171. Sapporo Clinical Laboratory's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Sapporo Clinical Laboratory (SSE:9776), the current Beta is -0.0171 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sapporo Clinical Laboratory (SSE:9776) Overvalued in 2026?

Based on GuruFocus' analysis, Sapporo Clinical Laboratory stock appears to be overvalued. The current stock price of 円2,124.00 is trading 88.2% above its estimated GF Value™ of 円1,128.61.

Key valuation signals for SSE:9776:

  • Beta: -0.0171
  • GF Value™: 円1,128.61 vs. price of 円2,124.00 (88.2% above fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the SSE:9776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sapporo Clinical Laboratory Business Description

Address 18-9-1 Nishi Kita-Gojo, Chuo-ku Sapporo, Hokkaido, Sapporo, JPN, 060 0005
Sapporo Clinical Laboratory Inc. is a Japan based company engaged in offering clinical testing services. Its portfolio of services covers clinical examination, pathological examination, dispensing pharmacy, food hygiene environmental test, and radiation management. It is also engaged in the development of an integrated system for clinical testing.
66GF Score

Get the complete analysis for SSE:9776

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,124.00
Price
円1,128.61
GF Value